Send to

Choose Destination
Toxicol Sci. 2011 Jul;122(1):185-97. doi: 10.1093/toxsci/kfr090. Epub 2011 Apr 28.

Genomic profiling uncovers a molecular pattern for toxicological characterization of mutagens and promutagens in vitro.

Author information

Merck KGaA, Merck Serono, Toxicology, Darmstadt, Germany.


The aim of this study was to evaluate the suitability of global gene expression profiling for the characterization and identification of mutagens and promutagens in vitro. To enable detection of both mutagenic and promutagenic compounds, we cotreated HepG2 cells with a rat liver S9 fraction as metabolic activation system (MAS), supplementing the limited drug metabolic capability of HepG2 cells. Illumina BeadChip arrays were used to quantify gene expression changes after treatment with three well-known mutagenic, three promutagenic, as well as two non-genotoxic reference compounds for a period of 24 or 48 h. Statistical data analysis revealed 91 genes being most representative for the (pro-)genotoxic response. Several processes such as cellular differentiation and the complex interactive regulation of the stress and DNA damage response via the transcriptional modulators STAT1, SP1, and P53 were differentially regulated. The gene set evaluated was further used to predict the genotoxic characteristics of N-nitrosodiethylamine (DEN) after its metabolic activation. Although no clear response could be established in P53 activation experiments, DEN was classified correctly as nongenotoxic without S9 and genotoxic in the presence of the MAS by means of its transcriptomic pattern. Our data support that mechanistic profiling in vitro is a useful tool compared with single endpoint detections to predict genotoxicity.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center